Axa S.A. Twist Bioscience Corp Transaction History
Axa S.A.
- $32.8 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding TWST
# of Institutions
252Shares Held
65.9MCall Options Held
247KPut Options Held
203K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.94MShares$329 Million1.7% of portfolio
-
Black Rock Inc. New York, NY5.77MShares$273 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.46MShares$258 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.64MShares$220 Million0.25% of portfolio
-
Jpmorgan Chase & CO New York, NY3.61MShares$171 Million0.01% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.67B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...